Rx Analytic
Michael Goldstein is the founder of Rx Analytic, a company that specializes in developing drug-delivery technology and co-optimized inhalers. Prior to founding Rx Analytic, Goldstein was the EUV Mask Infrastructure Partnership and AIMS EUV Program Manager at SEMATECH. In this role, they were responsible for developing the Aerial Image Measurement System (AIMS) EUV tool with Zeiss, TSMC, Samsung, Intel, GlobalFoundries, and SK Hynix. Goldstein began their career as a physicist at Intel Corporation in 1995 and held various positions there until they left in 2011 to join SEMATECH.
Michael Goldstein received their Doctor of Philosophy in Physics from Dartmouth College. Michael also holds a Bachelor of Arts in Physics and Computer Engineering from Hampshire College. In addition, they have certification from Coursera in Financial Engineering & Risk Management Part II and Financial Engineering & Risk Management Part I.
This person is not in any teams
This person is not in any offices
Rx Analytic
1 followers
The idea behind Rx Analytic (RxA) was relatively simple. Nano-encapsulate inhalable drug particles to achieve a constant aerodynamic diameter, control of pharmacokinetics, and pharmaceutical stability. These attributes allow for highly efficient and targeted drug delivery to specific regions of pathology in the lungs, local treatment with medication that would otherwise need systemic delivery, and room temperature storage for oligonucleotides. The platform was being co-optimized with a dry powder inhaler.